(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYB5A mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:732318 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYB5A mRNA CTD PMID:36331819 1,2,4-trichlorobenzene increases activity EXP 6480464 1 more ... CTD PMID:8212004 1,2-dimethylhydrazine multiple interactions EXP 6480464 hesperetin inhibits the reaction [1, 2-Dimethylhydrazine results in increased activity of CYB5A protein] CTD PMID:19497424 1,2-dimethylhydrazine decreases expression ISO RGD:732318 6480464 1, 2-Dimethylhydrazine results in decreased expression of CYB5A mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases activity EXP 6480464 1, 2-Dimethylhydrazine results in increased activity of CYB5A protein CTD PMID:19497424 17alpha-ethynylestradiol increases expression ISO RGD:732318 6480464 Ethinyl Estradiol results in increased expression of CYB5A mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:732318 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYB5A mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:736806 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYB5A mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of CYB5A mRNA CTD PMID:20660070 , PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:732318 6480464 Dihydrotestosterone inhibits the reaction [Androgens deficiency results in increased expression of CYB5A mRNA] CTD PMID:29367455 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:31826744 2,3,7,8-tetrabromodibenzodioxine increases expression ISO RGD:732318 6480464 2 more ... CTD PMID:27604104 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYB5A mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYB5A mRNA CTD PMID:18796159 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732318 6480464 Tetrachlorodibenzodioxin results in increased expression of CYB5A mRNA, Tetrachlorodibenzodioxin results in increased expression of CYB5A protein CTD PMID:18796159 , PMID:27105554 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732318 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CYB5A mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYB5A mRNA CTD PMID:16214954 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732318 6480464 Tetrachlorodibenzodioxin affects the expression of CYB5A mRNA CTD PMID:21570461 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736806 6480464 Tetrachlorodibenzodioxin results in increased expression of CYB5A mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYB5A mRNA CTD PMID:18465118 , PMID:21215274 2-hydroxypropanoic acid affects expression ISO RGD:736806 6480464 Lactic Acid affects the expression of CYB5A mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:736806 6480464 beta-methylcholine affects the expression of CYB5A mRNA CTD PMID:21179406 2-tert-butylhydroquinone increases expression ISO RGD:732318 6480464 2-tert-butylhydroquinone results in increased expression of CYB5A mRNA CTD PMID:16014739 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736806 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CYB5A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:736806 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CYB5A protein CTD PMID:34186270 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:736806 6480464 CYB5A protein promotes the reaction [CYP2A6 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:15728263 4-nitroquinoline N-oxide increases activity EXP 6480464 4-Nitroquinoline-1-oxide results in increased activity of CYB5A protein CTD PMID:23499697 4-nitroquinoline N-oxide multiple interactions EXP 6480464 geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CYB5A protein] CTD PMID:23499697 7,12-dimethyltetraphene multiple interactions EXP 6480464 tangeretin inhibits the reaction [9 more ... CTD PMID:24995432 , PMID:27091720 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:24995432 , PMID:27091720 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYB5A mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:736806 6480464 Acrylamide results in decreased expression of CYB5A mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:736806 6480464 Aflatoxin B1 results in decreased expression of CYB5A mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:736806 6480464 Aflatoxin B1 results in decreased methylation of CYB5A gene CTD PMID:27153756 alfentanil multiple interactions ISO RGD:736806 6480464 CYB5A protein promotes the reaction [CYP3A4 protein affects the metabolism of Alfentanil], CYB5A protein promotes the reaction [CYP3A5 protein affects the metabolism of Alfentanil] CTD PMID:15557344 Allylamine increases expression EXP 6480464 Allylamine results in increased expression of CYB5A mRNA CTD PMID:15910882 alpha-hexachlorocyclohexane affects expression EXP 6480464 alpha-hexachlorocyclohexane affects the expression of CYB5A mRNA CTD PMID:17785943 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYB5A mRNA CTD PMID:16483693 anthracen-2-amine multiple interactions ISO RGD:736806 6480464 CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] CTD PMID:15728263 aristolochic acid A multiple interactions EXP 6480464 [CYP2C11 protein co-treated with CYB5A protein] results in increased abundance of aristolochic acid I metabolite more ... CTD PMID:21362632 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYB5A protein CTD PMID:8471063 arsane multiple interactions ISO RGD:736806 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYB5A mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:736806 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYB5A mRNA CTD PMID:32525701 arsenite(3-) increases expression ISO RGD:732318 6480464 arsenite results in increased expression of CYB5A mRNA CTD PMID:18929588 atrazine increases expression ISO RGD:732318 6480464 Atrazine results in increased expression of CYB5A protein CTD PMID:26775023 atrazine multiple interactions ISO RGD:732318 6480464 lycopene inhibits the reaction [Atrazine results in increased expression of CYB5A protein] CTD PMID:26775023 benzo[a]pyrene multiple interactions ISO RGD:732318 6480464 POR protein affects the reaction [Benzo(a)pyrene results in increased expression of CYB5A protein] CTD PMID:22759596 benzo[a]pyrene decreases expression ISO RGD:736806 6480464 Benzo(a)pyrene results in decreased expression of CYB5A mRNA CTD PMID:32234424 benzo[a]pyrene multiple interactions EXP 6480464 [CYP1A1 protein co-treated with CYB5A protein] results in increased oxidation of Benzo(a)pyrene more ... CTD PMID:24530354 benzo[a]pyrene increases expression ISO RGD:732318 6480464 Benzo(a)pyrene results in increased expression of CYB5A mRNA, Benzo(a)pyrene results in increased expression of CYB5A protein CTD PMID:21715664 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:736806 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:736806 6480464 benzo(b)fluoranthene results in increased expression of CYB5A mRNA CTD PMID:16269432 Benzo[k]fluoranthene increases expression ISO RGD:732318 6480464 benzo(k)fluoranthene results in increased expression of CYB5A mRNA CTD PMID:26377693 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of CYB5A mRNA CTD PMID:16648578 bisphenol A increases expression ISO RGD:736806 6480464 bisphenol A results in increased expression of CYB5A mRNA CTD PMID:20678512 bisphenol A decreases expression ISO RGD:732318 6480464 bisphenol A results in decreased expression of CYB5A mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYB5A mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:736806 6480464 bisphenol A affects the expression of CYB5A mRNA CTD PMID:30903817 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of CYB5A mRNA CTD PMID:31129395 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYB5A mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:736806 6480464 bisphenol B results in increased expression of CYB5A protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:736806 6480464 bisphenol F results in increased expression of CYB5A protein CTD PMID:34186270 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of CYB5A mRNA CTD PMID:12628495 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of CYB5A mRNA CTD PMID:17293106 carbamazepine increases expression ISO RGD:736806 6480464 Carbamazepine results in increased expression of CYB5A mRNA CTD PMID:17112801 carbon nanotube decreases expression ISO RGD:732318 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of CYB5A mRNA CTD PMID:18172885 cetrorelix multiple interactions ISO RGD:736806 6480464 [cetrorelix co-treated with testosterone enanthate] results in decreased expression of CYB5A mRNA CTD PMID:18160741 chlorzoxazone multiple interactions ISO RGD:736806 6480464 CYB5A protein promotes the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] CTD PMID:15728263 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CYB5A mRNA CTD PMID:18172885 cisplatin increases expression ISO RGD:736806 6480464 Cisplatin results in increased expression of CYB5A mRNA CTD PMID:27594783 citral multiple interactions EXP 6480464 citral inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5A protein] CTD PMID:32302048 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CYB5A mRNA CTD PMID:12851107 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of CYB5A mRNA CTD PMID:17602206 copper(II) sulfate decreases expression ISO RGD:736806 6480464 Copper Sulfate results in decreased expression of CYB5A mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:732318 6480464 Asbestos, Crocidolite results in decreased expression of CYB5A mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:736806 6480464 Cyclosporine results in decreased expression of CYB5A mRNA CTD PMID:20106945 , PMID:25562108 cyproconazole increases expression ISO RGD:732318 6480464 cyproconazole results in increased expression of CYB5A mRNA CTD PMID:22334560 cytarabine decreases expression ISO RGD:736806 6480464 Cytarabine results in decreased expression of CYB5A mRNA CTD PMID:21198554 dexamethasone increases expression ISO RGD:732318 6480464 Dexamethasone results in increased expression of CYB5A mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:736806 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CYB5A mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:736806 6480464 Dexamethasone results in increased expression of CYB5A mRNA CTD PMID:25047013 dibenz[a,h]anthracene increases expression ISO RGD:736806 6480464 1 more ... CTD PMID:16269432 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CYB5A mRNA CTD PMID:21266533 diethyl maleate increases expression ISO RGD:732318 6480464 diethyl maleate results in increased expression of CYB5A mRNA CTD PMID:25270620 diiodine multiple interactions EXP 6480464 [[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of CYB5A protein CTD PMID:30090431 dorsomorphin multiple interactions ISO RGD:736806 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:736806 6480464 Doxorubicin results in increased expression of CYB5A mRNA CTD PMID:29803840 epoxiconazole increases expression ISO RGD:732318 6480464 epoxiconazole results in increased expression of CYB5A mRNA CTD PMID:22334560 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYB5A mRNA CTD PMID:16946407 ethanol multiple interactions EXP 6480464 zingerone inhibits the reaction [Ethanol results in increased activity of CYB5A protein] CTD PMID:28442378 ethanol increases activity EXP 6480464 Ethanol results in increased activity of CYB5A protein CTD PMID:28442378 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CYB5A protein CTD PMID:23200777 ferroheme b multiple interactions ISO RGD:736806 6480464 [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 12-hydroxyellipticine], [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 13-hydroxyellipticine] CTD PMID:22390216 fipronil increases expression EXP 6480464 fipronil results in increased expression of CYB5A mRNA CTD PMID:23962444 fipronil multiple interactions ISO RGD:736806 6480464 [fipronil co-treated with DEET] results in increased expression of CYB5A mRNA CTD PMID:27091632 fipronil increases expression ISO RGD:736806 6480464 fipronil results in increased expression of CYB5A mRNA CTD PMID:27091632 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CYB5A mRNA CTD PMID:18035473 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYB5A mRNA CTD PMID:24793618 genistein decreases expression ISO RGD:732318 6480464 Genistein results in decreased expression of CYB5A mRNA CTD PMID:24967385 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CYB5A mRNA CTD PMID:21782745 genistein increases expression EXP 6480464 Genistein results in increased expression of CYB5A mRNA CTD PMID:21782745 genistein decreases expression ISO RGD:736806 6480464 Genistein results in decreased expression of CYB5A protein CTD PMID:20884965 genistein multiple interactions ISO RGD:736806 6480464 ESR2 promotes the reaction [Genistein results in decreased expression of CYB5A protein] CTD PMID:20884965 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CYB5A mRNA CTD PMID:33387578 geranial multiple interactions EXP 6480464 citral inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5A protein] CTD PMID:32302048 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CYB5A protein] CTD PMID:23499697 halothane multiple interactions ISO RGD:736806 6480464 diisopropyl 1, 3-dithiol-2-ylidenemalonate results in increased expression of [CYB5A protein results in increased metabolism of Halothane] CTD PMID:3689822 halothane increases metabolic processing ISO RGD:736806 6480464 CYB5A protein results in increased metabolism of Halothane CTD PMID:3689822 heme b multiple interactions ISO RGD:736806 6480464 [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 12-hydroxyellipticine], [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 13-hydroxyellipticine] CTD PMID:22390216 hesperetin multiple interactions EXP 6480464 hesperetin inhibits the reaction [1, 2-Dimethylhydrazine results in increased activity of CYB5A protein] CTD PMID:19497424 hydrogen peroxide affects expression ISO RGD:736806 6480464 Hydrogen Peroxide affects the expression of CYB5A mRNA CTD PMID:20044591 hydroxylamine increases reduction ISO RGD:736806 6480464 CYB5A protein results in increased reduction of Hydroxylamine CTD PMID:21447608 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CYB5A mRNA CTD PMID:18299717 indometacin multiple interactions ISO RGD:736806 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CYB5A mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:732318 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYB5A mRNA CTD PMID:36331819 isoniazide multiple interactions EXP 6480464 [Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA, silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA] CTD PMID:28619387 isoniazide decreases expression EXP 6480464 Isoniazid results in decreased expression of CYB5A mRNA CTD PMID:28619387 isotretinoin decreases expression ISO RGD:736806 6480464 Isotretinoin results in decreased expression of CYB5A mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:736806 6480464 Ivermectin results in decreased expression of CYB5A protein CTD PMID:32959892 lamivudine multiple interactions ISO RGD:732318 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of CYB5A mRNA CTD PMID:18313992 limonene increases expression EXP 6480464 limonene results in increased expression of CYB5A mRNA CTD PMID:12815608 lycopene multiple interactions ISO RGD:732318 6480464 lycopene inhibits the reaction [Atrazine results in increased expression of CYB5A protein] CTD PMID:26775023 m-xylene decreases expression EXP 6480464 3-xylene results in decreased expression of CYB5A mRNA CTD PMID:12815608 Malotilate multiple interactions ISO RGD:736806 6480464 diisopropyl 1, 3-dithiol-2-ylidenemalonate results in increased expression of [CYB5A protein results in increased metabolism of Halothane] CTD PMID:3689822 Malotilate increases expression ISO RGD:736806 6480464 diisopropyl 1, 3-dithiol-2-ylidenemalonate results in increased expression of CYB5A protein CTD PMID:3689822 mercury dibromide increases expression ISO RGD:736806 6480464 mercuric bromide results in increased expression of CYB5A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:736806 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5A mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYB5A mRNA CTD PMID:30467583 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CYB5A mRNA CTD PMID:21782745 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYB5A mRNA CTD PMID:21782745 methylmercury chloride decreases expression ISO RGD:736806 6480464 methylmercuric chloride results in decreased expression of CYB5A mRNA CTD PMID:23179753 , PMID:27188386 metoprolol affects metabolic processing ISO RGD:732318 6480464 CYB5A affects the metabolism of Metoprolol CTD PMID:20430864 N,N-diethyl-m-toluamide increases expression ISO RGD:736806 6480464 DEET results in increased expression of CYB5A mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide multiple interactions ISO RGD:736806 6480464 [fipronil co-treated with DEET] results in increased expression of CYB5A mRNA CTD PMID:27091632 N-Nitrosodi-n-propylamine multiple interactions ISO RGD:736806 6480464 CYB5A protein promotes the reaction [CYP2A6 protein results in increased activity of N-nitroso(di-n-propyl)amine], CYB5A protein promotes the reaction [CYP2E1 protein results in increased activity of N-nitroso(di-n-propyl)amine] CTD PMID:15728263 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYB5A protein more ... CTD PMID:19409407 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CYB5A protein CTD PMID:32302048 N-nitrosodiethylamine multiple interactions ISO RGD:736806 6480464 CYB5A protein promotes the reaction [CYP2A6 protein results in increased activity of Diethylnitrosamine], CYB5A protein promotes the reaction [CYP2E1 protein results in increased activity of Diethylnitrosamine] CTD PMID:15728263 N-nitrosodiethylamine multiple interactions ISO RGD:732318 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5A mRNA] CTD PMID:17942915 N-nitrosodiethylamine increases expression ISO RGD:732318 6480464 Diethylnitrosamine results in increased expression of CYB5A mRNA CTD PMID:17942915 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CYB5A mRNA CTD PMID:20360939 NADP zwitterion multiple interactions ISO RGD:736806 6480464 [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 12-hydroxyellipticine] more ... CTD PMID:22390216 NADP(+) multiple interactions ISO RGD:736806 6480464 [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated with NADP] results in increased chemical synthesis of 12-hydroxyellipticine] more ... CTD PMID:22390216 naphthalene decreases expression ISO RGD:732318 6480464 naphthalene results in decreased expression of CYB5A protein CTD PMID:19438287 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CYB5A mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CYB5A mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CYB5A mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:732318 6480464 Acetaminophen affects the expression of CYB5A mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYB5A mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:736806 6480464 Acetaminophen results in decreased expression of CYB5A mRNA CTD PMID:25704631 , PMID:29067470 paraquat increases expression ISO RGD:732318 6480464 Paraquat results in increased expression of CYB5A mRNA CTD PMID:21371552 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732318 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYB5A mRNA more ... CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:736806 6480464 perfluorooctanoic acid results in decreased expression of CYB5A protein CTD PMID:26879310 phenethyl caffeate multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CYB5A mRNA] CTD PMID:20360939 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYB5A protein, [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of CYB5A protein CTD PMID:19409407 , PMID:20935162 phenobarbital increases expression ISO RGD:732318 6480464 Phenobarbital results in increased expression of CYB5A mRNA CTD PMID:28541575 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYB5A mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:736806 6480464 Phenobarbital affects the expression of CYB5A mRNA CTD PMID:19084549 phenylmercury acetate increases expression ISO RGD:736806 6480464 Phenylmercuric Acetate results in increased expression of CYB5A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736806 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5A mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:736806 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYB5A mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO RGD:732318 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYB5A mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile affects expression EXP 6480464 Pregnenolone Carbonitrile affects the expression of CYB5A mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:732318 6480464 Pregnenolone Carbonitrile results in increased expression of CYB5A mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:736806 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYB5A mRNA CTD PMID:20660070 propiconazole increases expression ISO RGD:732318 6480464 propiconazole results in increased expression of CYB5A mRNA CTD PMID:21278054 , PMID:22334560 Propiverine affects binding EXP 6480464 propiverine binds to CYB5A protein CTD PMID:29273565 quercetin decreases expression ISO RGD:736806 6480464 Quercetin results in decreased expression of CYB5A mRNA CTD PMID:21632981 rac-lactic acid affects expression ISO RGD:736806 6480464 Lactic Acid affects the expression of CYB5A mRNA CTD PMID:30851411 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of CYB5A mRNA CTD PMID:18299717 resveratrol increases expression ISO RGD:732318 6480464 resveratrol results in increased expression of CYB5A mRNA CTD PMID:22610192 SB 431542 multiple interactions ISO RGD:736806 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silibinin multiple interactions EXP 6480464 Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA] CTD PMID:28619387 sodium arsenate multiple interactions ISO RGD:736806 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYB5A mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:732318 6480464 sodium arsenite results in increased expression of CYB5A mRNA CTD PMID:25270620 sodium arsenite affects expression ISO RGD:736806 6480464 sodium arsenite affects the expression of CYB5A mRNA CTD PMID:34032870 sodium perchlorate multiple interactions EXP 6480464 [[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of CYB5A protein CTD PMID:30090431 Sudan I multiple interactions EXP 6480464 CYB5A protein promotes the reaction [CYP1A1 protein results in increased oxidation of 1-phenylazo-2-naphthol] CTD PMID:17159775 Sudan I multiple interactions ISO RGD:736806 6480464 CYB5A protein inhibits the reaction [CYP2B6 protein results in increased oxidation of 1-phenylazo-2-naphthol] more ... CTD PMID:17159775 , PMID:19358889 sunitinib increases expression ISO RGD:736806 6480464 Sunitinib results in increased expression of CYB5A mRNA CTD PMID:31533062 tangeretin multiple interactions EXP 6480464 tangeretin inhibits the reaction [9 more ... CTD PMID:24995432 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [9 more ... CTD PMID:27091720 temozolomide decreases expression ISO RGD:736806 6480464 Temozolomide results in decreased expression of CYB5A mRNA CTD PMID:31758290 testosterone affects abundance ISO RGD:732318 6480464 CYB5A affects the abundance of Testosterone CTD PMID:20430864 testosterone enanthate multiple interactions ISO RGD:736806 6480464 [cetrorelix co-treated with testosterone enanthate] results in decreased expression of CYB5A mRNA CTD PMID:18160741 tetrachloroethene decreases expression ISO RGD:732318 6480464 Tetrachloroethylene results in decreased expression of CYB5A mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYB5A mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYB5A mRNA] CTD PMID:31150632 tetracycline decreases expression ISO RGD:732318 6480464 Tetracycline results in decreased expression of CYB5A mRNA CTD PMID:16917069 thapsigargin decreases expression ISO RGD:736806 6480464 Thapsigargin results in decreased expression of CYB5A mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYB5A mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CYB5A mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:736806 6480464 CYB5A protein affects the susceptibility to Topotecan CTD PMID:16217747 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of CYB5A mRNA CTD PMID:31129395 trichloroethene increases expression ISO RGD:732318 6480464 Trichloroethylene results in increased expression of CYB5A mRNA CTD PMID:19254012 trichostatin A increases expression ISO RGD:736806 6480464 trichostatin A results in increased expression of CYB5A mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736806 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5A mRNA CTD PMID:27188386 trovafloxacin increases expression ISO RGD:732318 6480464 trovafloxacin results in increased expression of CYB5A mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:732318 6480464 Tungsten results in increased expression of CYB5A mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:736806 6480464 Tunicamycin results in decreased expression of CYB5A mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:736806 6480464 Urethane results in decreased expression of CYB5A mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CYB5A mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:732318 6480464 Valproic Acid affects the expression of CYB5A mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:736806 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5A mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736806 6480464 Valproic Acid results in increased expression of CYB5A mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:736806 6480464 Valproic Acid affects the expression of CYB5A mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYB5A mRNA CTD PMID:23665938 zidovudine multiple interactions ISO RGD:732318 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of CYB5A mRNA CTD PMID:18313992 zidovudine decreases expression EXP 6480464 Zidovudine results in decreased expression of CYB5A mRNA CTD PMID:28619387 zidovudine multiple interactions EXP 6480464 [Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA, Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA] CTD PMID:28619387 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of CYB5A mRNA CTD PMID:18172885 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of CYB5A mRNA CTD PMID:18172885 zingerone multiple interactions EXP 6480464 zingerone inhibits the reaction [Ethanol results in increased activity of CYB5A protein] CTD PMID:28442378